Tag: Pharmaceutical Packaging

If you don’t find what you are looking for, try using a different term or contact us.

Featured image for a GMP Insiders article on USP Pharmacopeial Forum 52(5), showing regulatory documents clipped together. The issue includes proposals on oral drug product leachables, glycol impurity testing, and revisions to compendial Identification requirements.

USP PF 52(5): New General Chapter ⟨1664.5⟩ on Oral Drug Product Leachables, Revised ⟨469⟩ Glycol Test, and General Notices Revisions

USP Pharmacopeial Forum 52(5) introduces proposals covering oral drug product leachables, glycol impurity testing in ethoxylated substances, and revisions to...
Revised EU GMP Annex 19 published, with a regulatory document being stamped and the subtitle on reference and retention samples before September 2026.

Revised EU GMP Annex 19: What Changes for Reference and Retention Samples?

The 2026 revision of EU GMP Annex 19 introduces focused updates for reference and retention samples, mainly affecting parallel trade,...
Different types of pharmaceutical packaging — primary, secondary, and tertiary packaging illustration.

Different Types of Pharmaceutical Packaging Used in GMP

What are the types of pharmaceutical packaging? Primary, secondary, and tertiary packaging protect medicines through GMP-compliant systems....
New Drafts release in Pharmeuropa 37.4. October 2025.

Pharmeuropa 37.4: New Drafts Released for Public Consultation

Pharmeuropa 37.4 introduces updates to residual solvents (2.4.24), cannabis flower (3028), and rubber closures (3.2.9) to improve analytical clarity....
Primary vs Secondary Packaging in the Pharma Industry

Primary vs Secondary Packaging in Pharma Industry

Explore the critical role of primary vs secondary packaging in the pharmaceutical industry, highlighting differences, protection, preservation, and regulatory compliance....

BECOME A GMP INSIDER

Stay in touch and be the first to get the latest GMP News!